世界の生殖器ヘルペス治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Genital Herpes Treatment Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5752
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、生殖器ヘルペス治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アシクロビル、ファムシクロビル、バラシクロビル）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・生殖器ヘルペス治療薬の市場動向
・企業の競争状況、市場シェア
・生殖器ヘルペス治療薬の種類別市場規模と予測2016-2027（アシクロビル、ファムシクロビル、バラシクロビル）
・生殖器ヘルペス治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他）
・生殖器ヘルペス治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・生殖器ヘルペス治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・生殖器ヘルペス治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・生殖器ヘルペス治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・生殖器ヘルペス治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca, Plc.、Apotheca, Inc.、Asahi Kasei Pharma Corporation、Carlsbad Technology, Inc.、GlaxoSmithkline, Plc.、Mylan N.V.、Novartis AG.、Merck & Co., Inc.、Teva Pharmaceutical Industries Ltd.、Zydus Pharmaceuticals, Inc.）
・結論

Genital herpes is a sexually transmitted disease (STD). This STD causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. About 16 percentTrusted Source of people between the ages of 14 and 49 have this STD.

Market Analysis and Insights: Global Genital Herpes Treatment Drugs Market
The global Genital Herpes Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genital Herpes Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genital Herpes Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genital Herpes Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genital Herpes Treatment Drugs market.

Global Genital Herpes Treatment Drugs Scope and Market Size
Genital Herpes Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genital Herpes Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Acyclovir
Famciclovir
Valacyclovir

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca, Plc.
Apotheca, Inc.
Asahi Kasei Pharma Corporation
Carlsbad Technology, Inc.
GlaxoSmithkline, Plc.
Mylan N.V.
Novartis AG.
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Zydus Pharmaceuticals, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genital Herpes Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acyclovir
1.2.3 Famciclovir
1.2.4 Valacyclovir
1.3 Market by Application
1.3.1 Global Genital Herpes Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Genital Herpes Treatment Drugs Market Perspective (2016-2027)
2.2 Genital Herpes Treatment Drugs Growth Trends by Regions
2.2.1 Genital Herpes Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Genital Herpes Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Genital Herpes Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Genital Herpes Treatment Drugs Industry Dynamic
2.3.1 Genital Herpes Treatment Drugs Market Trends
2.3.2 Genital Herpes Treatment Drugs Market Drivers
2.3.3 Genital Herpes Treatment Drugs Market Challenges
2.3.4 Genital Herpes Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Genital Herpes Treatment Drugs Players by Revenue
3.1.1 Global Top Genital Herpes Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Genital Herpes Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Genital Herpes Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Genital Herpes Treatment Drugs Revenue
3.4 Global Genital Herpes Treatment Drugs Market Concentration Ratio
3.4.1 Global Genital Herpes Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genital Herpes Treatment Drugs Revenue in 2020
3.5 Genital Herpes Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Genital Herpes Treatment Drugs Product Solution and Service
3.7 Date of Enter into Genital Herpes Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Genital Herpes Treatment Drugs Breakdown Data by Type
4.1 Global Genital Herpes Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Genital Herpes Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Genital Herpes Treatment Drugs Breakdown Data by Application
5.1 Global Genital Herpes Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Genital Herpes Treatment Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Genital Herpes Treatment Drugs Market Size (2016-2027)
6.2 North America Genital Herpes Treatment Drugs Market Size by Type
6.2.1 North America Genital Herpes Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Genital Herpes Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Genital Herpes Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Genital Herpes Treatment Drugs Market Size by Application
6.3.1 North America Genital Herpes Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Genital Herpes Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Genital Herpes Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Genital Herpes Treatment Drugs Market Size by Country
6.4.1 North America Genital Herpes Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Genital Herpes Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Genital Herpes Treatment Drugs Market Size (2016-2027)
7.2 Europe Genital Herpes Treatment Drugs Market Size by Type
7.2.1 Europe Genital Herpes Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Genital Herpes Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Genital Herpes Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Genital Herpes Treatment Drugs Market Size by Application
7.3.1 Europe Genital Herpes Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Genital Herpes Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Genital Herpes Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Genital Herpes Treatment Drugs Market Size by Country
7.4.1 Europe Genital Herpes Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Genital Herpes Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Genital Herpes Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Genital Herpes Treatment Drugs Market Size (2016-2027)
9.2 Latin America Genital Herpes Treatment Drugs Market Size by Type
9.2.1 Latin America Genital Herpes Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Genital Herpes Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Genital Herpes Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Genital Herpes Treatment Drugs Market Size by Application
9.3.1 Latin America Genital Herpes Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Genital Herpes Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Genital Herpes Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Genital Herpes Treatment Drugs Market Size by Country
9.4.1 Latin America Genital Herpes Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Genital Herpes Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Genital Herpes Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca, Plc.
11.1.1 AstraZeneca, Plc. Company Details
11.1.2 AstraZeneca, Plc. Business Overview
11.1.3 AstraZeneca, Plc. Genital Herpes Treatment Drugs Introduction
11.1.4 AstraZeneca, Plc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021)
11.1.5 AstraZeneca, Plc. Recent Development
11.2 Apotheca, Inc.
11.2.1 Apotheca, Inc. Company Details
11.2.2 Apotheca, Inc. Business Overview
11.2.3 Apotheca, Inc. Genital Herpes Treatment Drugs Introduction
11.2.4 Apotheca, Inc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021)
11.2.5 Apotheca, Inc. Recent Development
11.3 Asahi Kasei Pharma Corporation
11.3.1 Asahi Kasei Pharma Corporation Company Details
11.3.2 Asahi Kasei Pharma Corporation Business Overview
11.3.3 Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Introduction
11.3.4 Asahi Kasei Pharma Corporation Revenue in Genital Herpes Treatment Drugs Business (2016-2021)
11.3.5 Asahi Kasei Pharma Corporation Recent Development
11.4 Carlsbad Technology, Inc.
11.4.1 Carlsbad Technology, Inc. Company Details
11.4.2 Carlsbad Technology, Inc. Business Overview
11.4.3 Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Introduction
11.4.4 Carlsbad Technology, Inc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021)
11.4.5 Carlsbad Technology, Inc. Recent Development
11.5 GlaxoSmithkline, Plc.
11.5.1 GlaxoSmithkline, Plc. Company Details
11.5.2 GlaxoSmithkline, Plc. Business Overview
11.5.3 GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Introduction
11.5.4 GlaxoSmithkline, Plc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021)
11.5.5 GlaxoSmithkline, Plc. Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Details
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Genital Herpes Treatment Drugs Introduction
11.6.4 Mylan N.V. Revenue in Genital Herpes Treatment Drugs Business (2016-2021)
11.6.5 Mylan N.V. Recent Development
11.7 Novartis AG.
11.7.1 Novartis AG. Company Details
11.7.2 Novartis AG. Business Overview
11.7.3 Novartis AG. Genital Herpes Treatment Drugs Introduction
11.7.4 Novartis AG. Revenue in Genital Herpes Treatment Drugs Business (2016-2021)
11.7.5 Novartis AG. Recent Development
11.8 Merck & Co., Inc.
11.8.1 Merck & Co., Inc. Company Details
11.8.2 Merck & Co., Inc. Business Overview
11.8.3 Merck & Co., Inc. Genital Herpes Treatment Drugs Introduction
11.8.4 Merck & Co., Inc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021)
11.8.5 Merck & Co., Inc. Recent Development
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Details
11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Introduction
11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Genital Herpes Treatment Drugs Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.10 Zydus Pharmaceuticals, Inc.
11.10.1 Zydus Pharmaceuticals, Inc. Company Details
11.10.2 Zydus Pharmaceuticals, Inc. Business Overview
11.10.3 Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Introduction
11.10.4 Zydus Pharmaceuticals, Inc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021)
11.10.5 Zydus Pharmaceuticals, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Genital Herpes Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acyclovir
Table 3. Key Players of Famciclovir
Table 4. Key Players of Valacyclovir
Table 5. Global Genital Herpes Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Genital Herpes Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Genital Herpes Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Genital Herpes Treatment Drugs Market Share by Regions (2016-2021)
Table 9. Global Genital Herpes Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Genital Herpes Treatment Drugs Market Share by Regions (2022-2027)
Table 11. Genital Herpes Treatment Drugs Market Trends
Table 12. Genital Herpes Treatment Drugs Market Drivers
Table 13. Genital Herpes Treatment Drugs Market Challenges
Table 14. Genital Herpes Treatment Drugs Market Restraints
Table 15. Global Genital Herpes Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Genital Herpes Treatment Drugs Market Share by Players (2016-2021)
Table 17. Global Top Genital Herpes Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genital Herpes Treatment Drugs as of 2020)
Table 18. Ranking of Global Top Genital Herpes Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Genital Herpes Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Genital Herpes Treatment Drugs Product Solution and Service
Table 22. Date of Enter into Genital Herpes Treatment Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genital Herpes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Genital Herpes Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Genital Herpes Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Genital Herpes Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Genital Herpes Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Genital Herpes Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Genital Herpes Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Genital Herpes Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Genital Herpes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Genital Herpes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Genital Herpes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Genital Herpes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Genital Herpes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Genital Herpes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Genital Herpes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Genital Herpes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Genital Herpes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Genital Herpes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Genital Herpes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Genital Herpes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Genital Herpes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Genital Herpes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Genital Herpes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Genital Herpes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Genital Herpes Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Genital Herpes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Genital Herpes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Genital Herpes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Genital Herpes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Genital Herpes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Genital Herpes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Genital Herpes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Genital Herpes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Genital Herpes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Genital Herpes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Genital Herpes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca, Plc. Company Details
Table 63. AstraZeneca, Plc. Business Overview
Table 64. AstraZeneca, Plc. Genital Herpes Treatment Drugs Product
Table 65. AstraZeneca, Plc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca, Plc. Recent Development
Table 67. Apotheca, Inc. Company Details
Table 68. Apotheca, Inc. Business Overview
Table 69. Apotheca, Inc. Genital Herpes Treatment Drugs Product
Table 70. Apotheca, Inc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 71. Apotheca, Inc. Recent Development
Table 72. Asahi Kasei Pharma Corporation Company Details
Table 73. Asahi Kasei Pharma Corporation Business Overview
Table 74. Asahi Kasei Pharma Corporation Genital Herpes Treatment Drugs Product
Table 75. Asahi Kasei Pharma Corporation Revenue in Genital Herpes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 76. Asahi Kasei Pharma Corporation Recent Development
Table 77. Carlsbad Technology, Inc. Company Details
Table 78. Carlsbad Technology, Inc. Business Overview
Table 79. Carlsbad Technology, Inc. Genital Herpes Treatment Drugs Product
Table 80. Carlsbad Technology, Inc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 81. Carlsbad Technology, Inc. Recent Development
Table 82. GlaxoSmithkline, Plc. Company Details
Table 83. GlaxoSmithkline, Plc. Business Overview
Table 84. GlaxoSmithkline, Plc. Genital Herpes Treatment Drugs Product
Table 85. GlaxoSmithkline, Plc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 86. GlaxoSmithkline, Plc. Recent Development
Table 87. Mylan N.V. Company Details
Table 88. Mylan N.V. Business Overview
Table 89. Mylan N.V. Genital Herpes Treatment Drugs Product
Table 90. Mylan N.V. Revenue in Genital Herpes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 91. Mylan N.V. Recent Development
Table 92. Novartis AG. Company Details
Table 93. Novartis AG. Business Overview
Table 94. Novartis AG. Genital Herpes Treatment Drugs Product
Table 95. Novartis AG. Revenue in Genital Herpes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 96. Novartis AG. Recent Development
Table 97. Merck & Co., Inc. Company Details
Table 98. Merck & Co., Inc. Business Overview
Table 99. Merck & Co., Inc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 100. Merck & Co., Inc. Recent Development
Table 101. Teva Pharmaceutical Industries Ltd. Company Details
Table 102. Teva Pharmaceutical Industries Ltd. Business Overview
Table 103. Teva Pharmaceutical Industries Ltd. Genital Herpes Treatment Drugs Product
Table 104. Teva Pharmaceutical Industries Ltd. Revenue in Genital Herpes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 105. Teva Pharmaceutical Industries Ltd. Recent Development
Table 106. Zydus Pharmaceuticals, Inc. Company Details
Table 107. Zydus Pharmaceuticals, Inc. Business Overview
Table 108. Zydus Pharmaceuticals, Inc. Genital Herpes Treatment Drugs Product
Table 109. Zydus Pharmaceuticals, Inc. Revenue in Genital Herpes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 110. Zydus Pharmaceuticals, Inc. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genital Herpes Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Acyclovir Features
Figure 3. Famciclovir Features
Figure 4. Valacyclovir Features
Figure 5. Global Genital Herpes Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Genital Herpes Treatment Drugs Report Years Considered
Figure 10. Global Genital Herpes Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Genital Herpes Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Genital Herpes Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Genital Herpes Treatment Drugs Market Share by Regions (2022-2027)
Figure 14. Global Genital Herpes Treatment Drugs Market Share by Players in 2020
Figure 15. Global Top Genital Herpes Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genital Herpes Treatment Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Genital Herpes Treatment Drugs Revenue in 2020
Figure 17. Global Genital Herpes Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Genital Herpes Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Genital Herpes Treatment Drugs Market Share by Type (2016-2027)
Figure 21. North America Genital Herpes Treatment Drugs Market Share by Application (2016-2027)
Figure 22. North America Genital Herpes Treatment Drugs Market Share by Country (2016-2027)
Figure 23. United States Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Genital Herpes Treatment Drugs Market Share by Type (2016-2027)
Figure 27. Europe Genital Herpes Treatment Drugs Market Share by Application (2016-2027)
Figure 28. Europe Genital Herpes Treatment Drugs Market Share by Country (2016-2027)
Figure 29. Germany Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Genital Herpes Treatment Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Genital Herpes Treatment Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Genital Herpes Treatment Drugs Market Share by Region (2016-2027)
Figure 39. China Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Genital Herpes Treatment Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Genital Herpes Treatment Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Genital Herpes Treatment Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Genital Herpes Treatment Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Genital Herpes Treatment Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Genital Herpes Treatment Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Genital Herpes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AstraZeneca, Plc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2016-2021)
Figure 59. Apotheca, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2016-2021)
Figure 60. Asahi Kasei Pharma Corporation Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2016-2021)
Figure 61. Carlsbad Technology, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2016-2021)
Figure 62. GlaxoSmithkline, Plc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2016-2021)
Figure 63. Mylan N.V. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2016-2021)
Figure 64. Novartis AG. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2016-2021)
Figure 65. Merck & Co., Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2016-2021)
Figure 67. Zydus Pharmaceuticals, Inc. Revenue Growth Rate in Genital Herpes Treatment Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の生殖器ヘルペス治療市場規模・現状・予測（2021年-2027年）

Global Genital Herpes Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4255 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、生殖器ヘルペス治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アシクロビル、バラシクロビル、ファムシクロビル）、用途別市場規模（HSV-1、HSV-2）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の生殖器ヘルペス研究開発パイプライン市場規模・現状・予測（2021年-2027年）

Global Genital Herpes Research and Development Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-5457 2021年6月 124Pages
QYResearch社発行の本調査レポートでは、生殖器ヘルペス研究開発パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アシクロビル、アスピダセプト、G-103、GEN-003、GV-2207、ヘルペス-I、HSV-529、プリテリビル、...

世界の帯状疱疹治療市場規模・現状・予測（2021年-2027年）

Global Herpes Zoster Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4311 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、帯状疱疹治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所、その他）、用途別市場規模（病院、診療所、ホームケア用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の口唇ヘルペス治療＆予防市場規模・現状・予測（2021年-2027年）

Global Treatment and Prevention of Herpes Labialis Market Size, Status and Forecast 2021-2027
QFJ1-4981 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、口唇ヘルペス治療＆予防の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他）、用途別市場規模（外用、経口、注射）、主要地域別市場規模（北...

世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年）

Global Viral Pneumonia Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5025 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ウイルス性肺炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リバビリン、アシクロビル、ガンシクロビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模...

世界の副鼻腔炎治療薬市場規模・現状・予測（2021年-2027年）

Global Sinusitis Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6007 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、副鼻腔炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、NSAIDS、充血除去剤・粘液溶解剤、鼻洗浄キット）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界の勃起不全治療薬市場規模・現状・予測（2021年-2027年）

Global Erectile Dysfunction Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5727 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、勃起不全治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホスホジエステラーゼ5型阻害剤、プロスタグランジンE1）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の遅発性ジスキネジア(TD)治療薬市場規模・現状・予測（2021年-2027年）

Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6032 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、遅発性ジスキネジア(TD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バルベナジン、デュテトラベナジン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の尿失禁治療薬市場規模・現状・予測（2021年-2027年）

Global Urinary Incontinence Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6059 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、尿失禁治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痙薬、筋弛緩薬、α遮断薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の生殖器ヘルペス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Genital Herpes Treatment Market The global Genital Herpes Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
世界の生殖器ヘルペス研究開発パイプライン市場規模・現状・予測（2021年-2027年） In 2021, the global Genital Herpes Research and Development Pipeline market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global Genital Herpes Research and Development Pipeline status, futur…
世界の口唇ヘルペス治療＆予防市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Treatment and Prevention of Herpes Labialis Market The global Treatment and Prevention of Herpes Labialis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
世界の帯状疱疹治療市場規模・現状・予測（2021年-2027年） Herpes Zoster, also known as zoster or shingles, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide stripe either on the left or right side of the body or face. Two to four days before the rash occurs there may be ti…
世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…